These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6258196

  • 1. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F, Camussi G.
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [Abstract] [Full Text] [Related]

  • 2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 3. The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.
    Hardwick RA, Hellums JD, Peterson DM, Moake JL, Olson JD.
    Blood; 1981 Oct 01; 58(4):678-81. PubMed ID: 7023570
    [Abstract] [Full Text] [Related]

  • 4. Effects of PGI2 and di-butyryl cyclic-AMP on platelets exposed to shear stress.
    Hardwick RA, Hellums JD, Peterson DM, Moake J, Olson J.
    Trans Am Soc Artif Intern Organs; 1981 Oct 01; 27():192-6. PubMed ID: 6277071
    [No Abstract] [Full Text] [Related]

  • 5. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
    Jørgensen KA, Dyerberg J, Stoffersen E.
    Pharmacol Res Commun; 1979 Jul 01; 11(7):605-15. PubMed ID: 388470
    [No Abstract] [Full Text] [Related]

  • 6. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
    Camussi G, Tetta C, Segoloni G, Chiara Deregibus M, Bussolino F.
    Agents Actions; 1981 Dec 01; 11(6-7):550-3. PubMed ID: 7041569
    [Abstract] [Full Text] [Related]

  • 7. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF).
    Cox CP, Linden J, Said SI.
    Peptides; 1984 Dec 01; 5(2):325-8. PubMed ID: 6206481
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of platelet aggregation and elevation of cyclic-AMP levels in platelets by 13,14-dehydro PGI2 methyl ester.
    Malmsten C, Claesson HE, Fried J.
    Prostaglandins Med; 1980 Jun 01; 4(6):453-63. PubMed ID: 6251494
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition and subsequent enhancement of platelet responsiveness by prostacyclin in the rabbit. Relationship to platelet adenosine 3',5'-cyclic monophosphate.
    Vanderwel M, Haslam RJ.
    J Clin Invest; 1985 Jul 01; 76(1):233-40. PubMed ID: 2991338
    [Abstract] [Full Text] [Related]

  • 11. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ, Moncada S, Whiting F, Vane JR.
    Prostaglandins; 1980 Apr 01; 19(4):605-27. PubMed ID: 6992234
    [Abstract] [Full Text] [Related]

  • 12. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML, Jaffe EA.
    Prostaglandins; 1980 Dec 01; 20(6):1103-16. PubMed ID: 7010448
    [Abstract] [Full Text] [Related]

  • 13. Effect of platelet-activating factor (PAF) on human platelets.
    Chesney CM, Pifer DD, Byers LW, Muirhead EE.
    Blood; 1982 Mar 01; 59(3):582-5. PubMed ID: 7037068
    [Abstract] [Full Text] [Related]

  • 14. Translocation-independent activation of protein kinase C by platelet-activating factor, thrombin and prostacyclin. Lack of correlation with polyphosphoinositide hydrolysis in rabbit platelets.
    Salari H, Duronio V, Howard S, Demos M, Pelech SL.
    Biochem J; 1990 May 01; 267(3):689-96. PubMed ID: 2160234
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1978 Sep 01; 16(3):373-88. PubMed ID: 364545
    [Abstract] [Full Text] [Related]

  • 16. Heparin neutralization of PGI2: effects upon platelets.
    Saba HI, Saba SR, Blackburn CA, Hartmann RC, Mason RG.
    Science; 1979 Aug 03; 205(4405):499-501. PubMed ID: 377493
    [Abstract] [Full Text] [Related]

  • 17. Platelet sensitivity to adenosine diphosphate and to prostacyclin in diabetic patients.
    Onodera H, Hirata T, Sugawara H, Sugai K, Yoda B, Toyota T, Goto Y.
    Tohoku J Exp Med; 1982 Aug 03; 137(4):423-8. PubMed ID: 6750843
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP.
    Bussolino F, Benveniste J.
    Immunology; 1980 Jul 03; 40(3):367-76. PubMed ID: 6159308
    [Abstract] [Full Text] [Related]

  • 19. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 03; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 20. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J.
    Br J Haematol; 1980 Nov 03; 46(3):455-64. PubMed ID: 6778498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.